Bristol Myers Slumps On Heart Drug Failure — Taking Cytokinetics With It
Bristol Myers Squibb stock skidded late Monday, tugging Cytokinetics lower, after Bristol's drug, Camzyos, failed in a heart disease study. The post Bristol Myers Slumps On Heart Drug Failure — Taking Cytokinetics With It appeared first on Investor's Business Daily.
Bristol Myers Squibb stock skidded late Monday, tugging Cytokinetics lower, after Bristol's drug, Camzyos, failed in a heart disease study.
The post Bristol Myers Slumps On Heart Drug Failure — Taking Cytokinetics With It appeared first on Investor's Business Daily.
iShook Opinion
"iShook Opinion" by Beni E Rachmanov, CEO & Founder of iShook. Explore captivating perspectives on entertainment, lifestyle, and sports at ishookdaily.com. Your go-to for engaging insights.
